Literature DB >> 19262499

Effects of salt substitute on pulse wave analysis among individuals at high cardiovascular risk in rural China: a randomized controlled trial.

Jihong Hu1, Xiongjing Jiang, Nicole Li, Xuequn Yu, Vlado Perkovic, Bailing Chen, Liancheng Zhao, Bruce Neal, Yangfeng Wu.   

Abstract

Reduced-sodium, increased-potassium salt substitutes lower blood pressure but may also have direct effects on vascular structure and arterial function. This study aimed to test the effects of long-term salt substitution on indices of these outcomes. The China Salt Substitute Study was a randomized, controlled trial designed to establish the effects of salt substitute (65% sodium chloride, 25% potassium chloride, 10% magnesium sulfate) compared with regular salt (100% sodium chloride) on blood pressure among 600 high-risk individuals living in six rural areas in northern China over a 12-month intervention period. Data on central aortic blood pressure, aortic pressure augmentation (AUG), augmentation index (AIx), the differences of the peak of first and baseline waves (P(1)-P(0)) and pulse wave reflection time (RT) were collected at randomization and at the completion of follow-up in 187 participants using the Sphygmocor pulse wave analysis system. Mean baseline blood pressure was 150.1/91.4 mm Hg, mean age was 58.4 years, 41% were male and three quarters had a history of vascular disease. After 12 months of intervention, there were significant net reductions in peripheral (7.4 mm Hg, P=0.009) and central (6.9 mm Hg, P=0.011) systolic blood pressure levels and central pulse pressure (4.5 mm Hg, P=0.012) and correspondingly there was a significant net reduction in P(1)-P(0) (3.0 mm Hg, P=0.007), borderline significant net reduction in AUG (1.5 mm Hg, P=0.074) and significant net increase in RT (2.59 ms, P=0.001). There were no detectable reductions in peripheral (2.8 mm Hg, P=0.14) or central (2.4 mm Hg, P=0.13) diastolic blood pressure levels or AIx (0.06%, P=0.96). In conclusion, over the 12-month study period the salt substitute significantly reduced not only peripheral and central systolic blood pressure but also reduced arterial stiffness.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19262499     DOI: 10.1038/hr.2009.7

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  12 in total

1.  2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Robert H Eckel; John M Jakicic; Jamy D Ard; Janet M de Jesus; Nancy Houston Miller; Van S Hubbard; I-Min Lee; Alice H Lichtenstein; Catherine M Loria; Barbara E Millen; Cathy A Nonas; Frank M Sacks; Sidney C Smith; Laura P Svetkey; Thomas A Wadden; Susan Z Yanovski; Karima A Kendall; Laura C Morgan; Michael G Trisolini; George Velasco; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal:  Circulation       Date:  2013-11-12       Impact factor: 29.690

2.  Relationships between urinary electrolytes excretion and central hemodynamics, and arterial stiffness in hypertensive patients.

Authors:  Weizhong Han; Xiao Han; Ningling Sun; Yunchao Chen; Shiliang Jiang; Min Li
Journal:  Hypertens Res       Date:  2017-03-02       Impact factor: 3.872

Review 3.  Replacing salt with low-sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women.

Authors:  Amanda Brand; Marianne E Visser; Anel Schoonees; Celeste E Naude
Journal:  Cochrane Database Syst Rev       Date:  2022-08-10

4.  Central Blood Pressure Responses to Dietary Sodium and Potassium Interventions.

Authors:  Xiaolong Xing; Fangchao Liu; Xueli Yang; Chen Huang; Dingding Zhang; Shufeng Chen; Jichun Chen; Jianxin Li; Zhendong Liu; Fanghong Lu; Dongfeng Gu; Jianfeng Huang
Journal:  Am J Hypertens       Date:  2018-04-13       Impact factor: 2.689

Review 5.  Effect of dietary salt restriction on central blood pressure: A systematic review and meta-analysis of the intervention studies.

Authors:  Lanfranco D'Elia; Ersilia La Fata; Alfonso Giaquinto; Pasquale Strazzullo; Ferruccio Galletti
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-04-09       Impact factor: 3.738

6.  Modifiable risk factors for increased arterial stiffness in outpatient nephrology.

Authors:  Usama Elewa; Beatriz Fernandez-Fernandez; Raquel Alegre; Maria D Sanchez-Niño; Ignacio Mahillo-Fernández; Maria Vanessa Perez-Gomez; Hussein El-Fishawy; Dawlat Belal; Alberto Ortiz
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

Review 7.  Salt reduction in China: a state-of-the-art review.

Authors:  Shuai Shao; Yechu Hua; Ying Yang; Xiaojuan Liu; Jingruo Fan; An Zhang; Jingling Xiang; Mingjing Li; Lijing L Yan
Journal:  Risk Manag Healthc Policy       Date:  2017-02-22

8.  Associations of plasma atrial natriuretic peptide and electrolyte levels with essential hypertension.

Authors:  Guangmei Hu; Xinjuan Xu; Xiaohui Liang; Xiaoping Yang; Junshi Zhang; Zhulepiya Simayi; Yulan Chen
Journal:  Exp Ther Med       Date:  2013-03-06       Impact factor: 2.447

9.  Lower potassium intake is associated with increased wave reflection in young healthy adults.

Authors:  Shannon Lennon-Edwards; Brittany R Allman; Taylor A Schellhardt; Courtney R Ferreira; William B Farquhar; David G Edwards
Journal:  Nutr J       Date:  2014-04-28       Impact factor: 3.271

10.  Prevalence, awareness, treatment and control of hypertension and sodium intake in Jiangsu Province, China: a baseline study in 2014.

Authors:  Zhang Yongqing; Wu Ming; Su Jian; Luo Pengfei; Pan Xiaoqun; Dong Meihua; Lou Peian; Dong Jianmei; Zhou Guoyu; Yang Jie; Lin Ping; Xu Yan
Journal:  BMC Public Health       Date:  2016-01-21       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.